Jane Moseley

Years Active: 2020-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Jane Moseley, Tim Leest, Kristina Larsson, Armando Magrelli, Violeta Stoyanova-Beninska
Inherited retinal dystrophies and orphan designations in the European Union. European journal of ophthalmology (2024)
Jane Moseley, Tim Leest, Kristina Larsson, Armando Magrelli, Violeta Stoyanova-Beninska
Inherited retinal dystrophies and orphan designations in the European Union. European journal of ophthalmology (2024)
Marcio Silva, Jane Moseley, Thorsten Vetter, Jan Regnstrom, Maria Tome, Stiina Aarum, Francesca Cerreta, Elmer Schabel, Spiros Vamvakas
Patient-reported, observer-reported and performance outcomes in qualification procedures at the European Medicines Agency (EMA) 2013-2018. British journal of clinical pharmacology (2023)
Jane Moseley, Spiros Vamvakas, Michael Berntgen, Alison Cave, Xavier Kurz, Peter Arlett, Virginia Acha, Simon Bennett, Catherine Cohet, Solange Corriol-Rohou, Emma Du Four, Christelle Lamoril, Anja Langeneckert, Maren Koban, Muriel Pasté, Susan Sandler, Karin Van Baelen, Agnese Cangini, Sonia García, Mercè Obach, Emmanuel Gimenez Garcia, Leonor Varela Lema, Hanna-Mari Jauhonen, Piia Rannanheimo, Deborah Morrison, Marc Van De Casteele, Anna Strömgren, Anders Viberg, Amr Makady, Chantal Guilhaume
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines. British journal of clinical pharmacology 86 (6) (2020)

Jane Moseley.css-eqlu8i{font-size:small;padding-left:4px;}